ProfileGDS5822 / ILMN_1221009
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 70% 77% 75% 66% 74% 74% 81% 73% 75% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 150.370
GSM1276600PDAC Late Ablation Control 2109.977
GSM1276601PDAC Late Ablation Control 3120.875
GSM1276602PDAC Late Ablation 136.666
GSM1276603PDAC Late Ablation 278.774
GSM1276604PDAC Late Ablation 386.174
GSM1303940PDAC Late Ablation_anti-CTLA4 1143.881
GSM1303941PDAC Late Ablation_anti-CTLA4 286.773
GSM1303942PDAC Late Ablation_anti-CTLA4 3115.675